Oncosec Medical (ONCS) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ONCS Hot Sheet
Join SI Premium – FREE
Oncosec Medical (NASDAQ: ONCS) reported Q4 EPS of ($0.39), $0.04 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Oncosec Medical (ONCS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nebius soars on second quarter revenue beat
- Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
